Concepedia

Signal Evaluation

Signal Evaluation is a systematic pharmacovigilance process that critically assesses detected safety signals by integrating clinical, statistical, and epidemiological evidence to determine the likelihood and characteristics of a causal association, its impact on the benefit–risk balance, and the need for regulatory or risk-minimisation actions.

611

Publications

37.4K

Citations

2.5K

Authors

1K

Institutions

Publications per year

2017–2026

165

Parents

Children

Publications

611

Calculation of signal detection theory measures

Harold Stanislaw, Natasha Todorov · Behavior Research Methods, Instruments, & Computers · 1999 · 3.2K citations · Full text

, , +11

Biological signals as handicaps

Alan Grafen · Journal of Theoretical Biology · 1990 · 2.5K citations

, , +5

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

Stephen Evans, Patrick Waller, Sarah Davis · Pharmacoepidemiology and Drug Safety · 2001 · 1.7K citations

, , +16

A Wavelet-Based ECG Delineator: Evaluation on Standard Databases

Juan Pablo Martí­nez, Rute Almeida, Salvador Carrión Olmos et al. · IEEE Transactions on Biomedical Engineering · 2004 · 1.6K citations

, , +17

Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation

Allessie Ma · Medical Entomology and Zoology · 1985 · 573 citations

, , +11

1–5 of 611

Authors

2.5K

  1. GN
    G. Niklas Norén

    Uppsala Monitoring Centre, Sweden

    9 publications · 648 citations

    9

    h-index

  2. IR
    I. Ralph Edwards

    Uppsala Monitoring Centre, Sweden

    8 publications · 553 citations

    8

    h-index

  3. KC
    K C Kacir

    University of Massachusetts Amherst, United States

    6 publications · 140 citations

    6

    h-index

  4. AB
    Andrew Bate

    Uppsala Monitoring Centre, Sweden

    6 publications · 497 citations

    6

    h-index

  5. EV
    Eugène van Puijenbroek

    Netherlands Pharmacovigilance Centre Lareb, Netherlands

    6 publications · 454 citations

    6

    h-index

1–5 of 2.5K

Institutions

1K

  1. Uppsala Monitoring Centre

    Uppsala, Sweden

    17 h-index

    83 publications

    4.6K citations

  2. Harvard University

    Cambridge, United States

    16 h-index

    51 publications

    2K citations

  3. Inserm

    Paris, France

    12 h-index

    57 publications

    3.2K citations

  4. University of Oxford

    Oxford, United Kingdom

    9 h-index

    26 publications

    2.5K citations

  5. Brigham and Women's Hospital

    Boston, United States

    9 h-index

    29 publications

    1K citations

  6. Netherlands Pharmacovigilance Centre Lareb

    's-Hertogenbosch, The Netherlands

    9 h-index

    21 publications

    1.3K citations

  7. University of Groningen

    Groningen, The Netherlands

    8 h-index

    19 publications

    982 citations

  8. Pfizer (United States)

    New York, United States

    8 h-index

    15 publications

    650 citations

1–8 of 1K

Venues

  1. Drug Safety

    33 publications · 1.8K citations

    23

    h-index

  2. Analytical Chemistry

    25 publications · 2.2K citations

    19

    h-index

  3. Pharmacoepidemiology and Drug Safety

    29 publications · 2.9K citations

    18

    h-index

  4. 14

    h-index

  5. IEEE Transactions on Biomedical Engineering

    11 publications · 2.3K citations

    11

    h-index

1–5